OCM
GILD icon

Orleans Capital Management’s Gilead Sciences GILD Stock Holding History

Orleans Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Buy
14,186
+3,334
+31% +$439K 0.93% 38
2026
Q1 		$1.51M Buy
10,852
+248
+2% +$34.7K 1.02% 37
2025
Q4 		$1.3M Buy
10,604
+3,024
+40% +$367K 0.81% 39
2025
Q3 		$841K Sell
7,580
-965
-11% -$110K 0.54% 52
2025
Q2 		$947K Buy
+8,545
New +$909K 0.5% 54
2018
Q3 		– Sell
-12,073
Closed -$855K – 83
2018
Q2 		$855K Sell
12,073
-240
-2% -$16.9K 0.62% 54
2018
Q1 		$928K Buy
12,313
+386
+3% +$30.7K 0.68% 50
2017
Q4 		$854K Sell
11,927
-5,090
-30% -$387K 0.61% 55
2017
Q3 		$1.38M Buy
17,017
+6,588
+63% +$504K 1.03% 40
2017
Q2 		$738K Sell
10,429
-75
-0.7% -$4.99K 0.52% 57
2017
Q1 		$713K Hold
10,504
– – 0.5% 59
2016
Q4 		$752K Sell
10,504
-5,595
-35% -$416K 0.54% 59
2016
Q3 		$1.27M Buy
16,099
+625
+4% +$50.8K 0.88% 50
2016
Q2 		$1.29M Buy
15,474
+2,060
+15% +$183K 0.9% 51
2016
Q1 		$1.23M Buy
13,414
+195
+1% +$17.6K 0.93% 51
2015
Q4 		$1.34M Buy
13,219
+7,253
+122% +$755K 1.03% 43
2015
Q3 		$586K Buy
+5,966
New +$663K 0.47% 64

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Orleans Capital Management's GILD Position: Q2 2026 in Review

Orleans Capital Management increased its Gilead Sciences (GILD) stake by 31% in Q2 2026, buying an estimated $439K and bringing the position to 14,186 shares worth $1.79M. The position accounts for 0.93% of the portfolio, ranked #38.

Orleans Capital Management first reported a position in GILD in Q3 2015 and has held it in 17 quarters since. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Orleans Capital Management held 14,186 shares of Gilead Sciences worth $1.79M as of Q2 2026.
  • Orleans Capital Management bought 3,334 Gilead Sciences shares in Q2 2026, an estimated $439K.
  • Gilead Sciences made up 0.93% of Orleans Capital Management's portfolio in Q2 2026, its #38 holding.
  • Orleans Capital Management first reported a position in Gilead Sciences in Q3 2015 and has held it in 17 quarters since.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Orleans Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.